This inventor holds 1 USPTO granted patent. Top assignees: Gc Corporation, Two Cells Co., Ltd.. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2011
Title: Tomohisa Okura: Innovator in Stem Cell Culturing Methods
Introduction
Tomohisa Okura is a notable inventor based in Hiroshima, Japan. He has made significant contributions to the field of stem cell research, particularly through his innovative culturing methods. His work aims to enhance the efficiency of selecting and proliferating mesenchymal stem cells.
Latest Patents
Tomohisa Okura holds a patent for a culturing method of mesenchymal stem cells. This method allows for the efficient selection and proliferation of these cells without the need for exclusive separating devices or complicated operations. The process involves culturing mesenchymal stem cells by seeding various biological solutions in a liquid culture medium. This medium is primarily composed of water and has a specific gravity between 1.06 and 1.10 at 37°C. The culture is maintained at a temperature of 37±2°C on the ceiling side surface of the vessel. The specific gravity is regulated using selected compounds, enhancing the overall efficiency of the culturing process.
Career Highlights
Throughout his career, Tomohisa Okura has worked with several companies, including Gc Corporation and Two Cells Co., Ltd. His experience in these organizations has contributed to his expertise in stem cell research and innovation.
Collaborations
Tomohisa Okura has collaborated with notable individuals in his field, including Yuhiro Sakai and Katsuyuki Yamanaka. These collaborations have furthered his research and development efforts in stem cell technology.
Conclusion
Tomohisa Okura's contributions to stem cell culturing methods represent a significant advancement in the field. His innovative approach not only simplifies the culturing process but also enhances the potential for medical applications. His work continues to inspire future research and development in stem cell technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile